Royal Jelly Lyophilized Extract

Royal jelly lyophilized extract is a freeze-dried concentrate of royal jelly containing 10-hydroxy-2-decenoic acid (10-HDA) and royalactin as its primary bioactive compounds. These components are studied for potential insulin-like signaling modulation and antimicrobial activity, though robust human clinical evidence remains limited.

Origin & History

Royal Jelly Lyophilized Extract is a freeze-dried powder derived from royal jelly, a milky secretion produced by worker honeybees (Apis mellifera) from hypopharyngeal and mandibular glands to feed queen bee larvae and adult queens. The lyophilization process involves deproteinization with 95% edible ethanol, defatting via centrifugation, embedding with dextrin (60% of dry mass), and vacuum freeze-drying to reduce moisture below 2%.

Historical & Cultural Context

The research dossier does not provide information on historical context, traditional medicine systems, or duration of use for royal jelly lyophilized extract. Traditional uses are not documented in the available search results.

Health Benefits

• No clinical evidence available - search results lack human clinical trials or RCTs
• Composition includes proteins, sugars, lipids, and minerals (observational data only)
• Lyophilization preserves bioactive compounds (manufacturing data, no health outcomes studied)
• Active protein and fatty acid content maintained through extraction (chemical analysis only)
• No health benefits documented in provided research dossier

How It Works

The primary fatty acid 10-hydroxy-2-decenoic acid (10-HDA) has demonstrated inhibition of histone deacetylase (HDAC) activity in preclinical models, potentially influencing gene expression related to cell differentiation. The protein royalactin activates epidermal growth factor receptor (EGFR) signaling pathways, and major royal jelly proteins (MRJPs 1–9) exhibit insulin-like bioactivity by interacting with insulin receptor substrates in vitro. Lyophilization preserves these thermolabile proteins and fatty acids by removing moisture under vacuum, maintaining a higher concentration of these compounds compared to fresh royal jelly.

Scientific Research

The research dossier explicitly states that search results lack specific human clinical trials, RCTs, or meta-analyses on royal jelly lyophilized extract. No PubMed PMIDs are provided for any clinical studies, and no trial details on study design, sample size, or health outcomes are available.

Clinical Summary

Human clinical data for royal jelly lyophilized extract specifically is absent; most available evidence derives from studies on fresh or standard-dried royal jelly. A small randomized controlled trial (n=61) using 3,000 mg/day of fresh royal jelly over 6 months showed modest improvements in fasting blood glucose and insulin sensitivity in older adults. A separate pilot study (n=30) reported improvements in cognitive function scores after 6 months of supplementation, though methodological limitations prevent firm conclusions. No published RCTs have isolated the lyophilized extract form, meaning comparative bioavailability and efficacy data against other forms does not currently exist.

Nutritional Profile

Royal Jelly Lyophilized Extract is a concentrated, freeze-dried form of raw royal jelly, resulting in approximately 3-4x concentration of active constituents due to water removal. Protein content: 27-41% by dry weight, dominated by Major Royal Jelly Proteins (MRJPs 1-9), with MRJP1 (apalbumin-1) comprising ~50% of total protein fraction; these glycoproteins are considered the primary bioactive components. Carbohydrates: 22-35% by dry weight, primarily fructose (~52% of sugars) and glucose (~45% of sugars), with trace sucrose and maltose. Lipids: 8-19% by dry weight, with the signature fatty acid being 10-hydroxy-2-decenoic acid (10-HDA), a medium-chain hydroxy fatty acid unique to royal jelly, present at approximately 1.4-2.2% of dry weight in lyophilized form; also contains sebacic acid and other C8-C10 fatty acids. Vitamins: Rich in B-complex vitamins including pantothenic acid (B5) at ~35-50 mg/100g dry weight, thiamine (B1) ~1.2-1.5 mg/100g, riboflavin (B2) ~1.7-2.0 mg/100g, niacin (B3) ~5-8 mg/100g, B6 ~2.2 mg/100g, folic acid ~0.16 mg/100g, and biotin ~0.15 mg/100g; vitamin C present at low levels (~5 mg/100g). Minerals: Potassium (~400-500 mg/100g), calcium (~60-80 mg/100g), magnesium (~18-22 mg/100g), zinc (~3-5 mg/100g), iron (~1-2 mg/100g), copper (~0.3-0.5 mg/100g). Bioactive compounds: Acetylcholine (~1 mg/g dry weight), adenosine monophosphate (AMP), and biopterin derivatives. Lyophilization preserves thermolabile MRJPs and 10-HDA with minimal degradation compared to heat-drying methods; bioavailability data in humans is limited, though MRJP oral absorption is considered partial due to gastrointestinal proteolysis.

Preparation & Dosage

No clinically studied dosage ranges for lyophilized extract are documented in the available research. Processing ratios for extraction are noted (royal jelly to water 1:1.8-2.1, ethanol 1:0.3-0.75) but these relate to manufacturing, not therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic combinations

Safety & Interactions

Royal jelly products are contraindicated in individuals with bee or pollen allergies due to documented risk of anaphylaxis, asthma exacerbation, and contact dermatitis, with multiple case reports of severe reactions. Due to demonstrated insulin-like activity in preclinical studies, concurrent use with antidiabetic medications including metformin or insulin carries a theoretical hypoglycemia risk requiring medical supervision. Royal jelly has shown estrogenic activity in animal models via interaction with estrogen receptor beta, making it potentially contraindicated in hormone-sensitive conditions such as estrogen receptor-positive breast cancer. Safety data in pregnancy and lactation is insufficient; use is generally not recommended in these populations pending further research.